Let's wait ...To Remember - Sirona-Biotechstock 2022_PRC_27. Juni 22.pdf
STRONG BUY Rating
We still stand firm in our belief that Sirona Biochem is a diamond in the rough, a sparkling gem that requires a bit of polishing but one that can potentially outshine all of the biotech stocks on the small-cap market.
If things pan out as expected, the company could become a major provider of patented active ingredients in the aesthetics, cosmetics, and pharmaceutical sector.
Further, once they get institutional commitment, Sirona Biochem will be playing at a completely different level.
Shareholders, particularly those that have stuck with the company, will finally have their day in the sun.